Article

Specialty Products Bring Distribution Challenges and Opportunities

Specialty products now represent a $100 billion industry. At CBI’s 2nd Annual Forum on Strategic Distribution Planning for Specialty Products, Gina Clarke, Chief Marketing Officer, AmerisourceBergen, offers a snapshot of the specialty market as well as the segments that are poised for growth—those therapeutic areas that have achieved the greatest commercial success over the past five years.

This September 22—23, attendees come together in Philadelphia to discuss strategies that will ensure pull through and increase product usage:

  • Examine underlying reasons in your product that influence distribution strategies for specialty products. Learn more, click here.
  • Discuss factors that drive the choice to have an open, limited or closed distribution network. Ensure your edge, click here.

The complex distribution of specialty pharmaceuticals dominates the responsibilities of many senior-level executives, such as those in trade and distribution, commercial operations, and marketing. With a strong agenda filled with practical strategies, Strategic Distribution Planning for Specialty Products offers valuable insight on trends and tactics to ensure access, use and reimbursement of this growing market segment.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com